For research use only. Not for therapeutic Use.
PG-11047（Cat No.:I042273）is an experimental drug currently under investigation for its potential in treating various forms of cancer. It is a selective inhibitor of the protein kinase CK2, which plays a crucial role in cell proliferation, survival, and cancer progression. By targeting CK2, PG-11047 aims to disrupt cancer cell growth and enhance the effectiveness of other treatments. Early preclinical studies have shown promising results, with PG-11047 demonstrating the ability to reduce tumor size and inhibit the spread of cancer. Its ongoing development could provide a novel therapeutic approach for cancer patients.
| Catalog Number | I042273 |
| CAS Number | 308145-19-9 |
| Synonyms | (Z)-N,N’-bis[3-(ethylamino)propyl]but-2-ene-1,4-diamine |
| Molecular Formula | C14H32N4 |
| Purity | ≥95% |
| IUPAC Name | (Z)-N,N'-bis[3-(ethylamino)propyl]but-2-ene-1,4-diamine |
| InChI | InChI=1S/C14H32N4/c1-3-15-11-7-13-17-9-5-6-10-18-14-8-12-16-4-2/h5-6,15-18H,3-4,7-14H2,1-2H3/b6-5- |
| InChIKey | XFWLTFZLLXVKDY-WAYWQWQTSA-N |
| SMILES | CCNCCCNC/C=C\CNCCCNCC |
